LTA and gastric cancer: In the study of TNF-β, an increase in this indicator was found in patients with gastric cancer at stages I, II, and III compared to the control group and the group of patients at stage IV of the disease (p1–2 < 0.001, p1–3 < 0.001, p1–4 < 0.001).